Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy

Summary

RATIONALE: Drugs used in chemotherapy, such as trabectedin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well trabectedin works in treating patients with metastatic pancreatic cancer after first-line chemotherapy.

Timeline

Start

2011-02

Primary completion

2012-12

Completion

2013-03

Drugs

Indications